CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma - Concepedia

Concepedia

Publication | Open Access

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma

DOI Full Paper Access

80

Citations

12

References

2012

Year

Jonathan Harris, Salvia Jain, Qinghu Ren, Alirezah Zarineh, Sherif Ibrahim

Diagnostic Pathology

Abstract

The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/1460518258831620.

References

	Year	Citations
A prospective randomized trial 平山克, 森昌造 Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) Clinical Trial DesignClinical Trial ManagementClinical TrialsRandomized Controlled TrialClinical Trial Evaluation	1995	1.6K
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma Christian Steidl, Tang Lee, Sohrab P. Shah, New England Journal of Medicine	2010	1.3K
Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells Tomás Álvaro, Marylène Lejeune, Teresa Salvadó-Usach, Clinical Cancer Research	2005	448
Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression Jeremy J.W. Chen, Yi‐Chen Lin, Pei‐Li Yao, Journal of Clinical Oncology	2004	372
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome Bruno Chetaille, François Bertucci, Pascal Finetti, Blood	2008	250
Expression of CD163 (Hemoglobin Scavenger Receptor) in Normal Tissues, Lymphomas, Carcinomas, and Sarcomas Is Largely Restricted to the Monocyte/Macrophage Lineage TuDung T. Nguyen, Erich Schwartz, Robert B. West, The American Journal of Surgical Pathology ImmunologyBlood CellPathologyImmunologic MechanismTumor Biology	2005	206
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma Abel Sánchez‐Aguilera Blood	2006	138
Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma Denize Azambuja, Yasodha Natkunam, Irène Biasoli, Annals of Oncology Lymphoid NeoplasiaTumor-associated MacrophagesImmunologyPathologyClassical Hodgkin	2011	98
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease Élisabeth Devilard, François Bertucci, Pascal Trempat, Oncogene Autoimmune DiseaseDisease MechanismMedicineImmunodeficienciesPathogenesis	2002	97
Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: A quantitative tissue microarray study in a large retrospective cohort of 267 patients Tomás Álvaro-Naranjo, Marylène Lejeune, Teresa Salvadó-Usach, Leukemia & lymphoma/Leukemia and lymphoma	2005	96

Page 1